arrow
J

Jacqueline L. Bender

Memorial University Newfoundland
H指数:25
被引数:3,102

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Examining healthcare staff views and experiences with equity, diversity, and inclusion (EDI) in a multi-disciplinary healthcare setting: A mixed methods needs assessment to advance inclusive excellence

考察多学科医疗环境中医疗人员对公平、多样性与包容性(EDI)的观点和经验:一项旨在推进包容性卓越的混合方法需求评估

2026-05-010
PRE
AA02, Poster Presentation: Quality of life and grade 3+ toxicities in older men with advanced prostate cancer receiving geriatric assessment and/or remote symptom monitoring in a randomized trial

AA02,海报展示:在随机试验中接受老年评估和/或远程症状监测的老年男性晚期前列腺癌患者的生活质量及3级及以上毒性反应情况

2026-03-130
PRE
AA01, Oral Presentation: Qualitative analysis of participants' interviews in a supportive care trial of geriatric assessment and/or remote symptom monitoring in older men with advanced prostate cancer

AA01,口头报告:在老年评估和/或远程症状监测对老年男性晚期前列腺癌患者支持性照护试验中,对参与者访谈的定性分析

2026-03-130
PRE
Developing a practice framework for patient navigation in cancer care: a Global Initiative to Advance Cancer Navigation for Better Outcomes (GINO) project

开发癌症护理中患者导航的实践框架:一项旨在通过癌症导航改善结局的全球倡议(GINO)项目

2026-02-230
OAAI
Investigating the Pre-Implementation Facilitators and Barriers of the Implementation of the Fear of Recurrence Therapy (FORT) Intervention in Canadian Cancer Centers

调查复发恐惧疗法(FORT)干预措施在加拿大癌症中心实施前的促进因素和阻碍因素

2025-10-070
OAAI
Emergency physicians' experiences managing patients with a suspected cancer diagnosis in Ontario, Canada: a qualitative study

加拿大安大略省急诊科医生管理疑似癌症诊断患者经验的定性研究

2025-09-080
OA
Collecting Data on the Social Determinants of Health to Advance Health Equity in Cancer Care in Canada: Patient and Community Perspectives

收集关于健康社会决定因素的数据以推进加拿大癌症护理中的健康公平:患者和社区视角

2025-08-230
PRE
Engaging Under-Represented Adolescents and Young Adults in Cancer Research: A Qualitative Exploration of Lived Experiences and Engagement Strategies

让代表性不足的青少年和青年参与癌症研究:对生活经历和参与策略的定性探索

2025-08-110
OAAI
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation
2024-07-012
OA